微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 62.68% | -0.96% | -0.86% | 48/142 | 52.32% | 佰仁医疗 | 88.31% | 行业排名> |
| 2026-06-30 | 63.22% | -2.27% | 3.6% | 47/142 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 61.03% | -6.07% | -3.45% | 54/142 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 63.21% | -5.95% | -0.13% | 51/142 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 63.29% | -5.7% | -2.17% | 47/142 | 52.29% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 64.7% | -3.4% | -0.43% | 40/142 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 64.97% | -4.42% | -3.33% | 40/142 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 67.21% | 6.69% | 0.14% | 37/142 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 67.11% | 1.05% | 0.22% | 38/142 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 66.97% | 2.69% | -1.48% | 41/142 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 67.97% | 3% | 7.9% | 38/142 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 63% | 7.65% | -5.15% | 52/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 66.41% | 11.61% | 1.84% | 39/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 65.21% | 7.79% | -1.18% | 43/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 65.99% | 3.66% | 12.77% | 40/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 58.52% | -5% | -1.66% | 61/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 59.51% | -4.06% | -1.64% | 58/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 60.5% | -2.28% | -4.97% | 56/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 63.66% | -0.71% | 3.35% | 48/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 61.6% | 1.2% | -0.68% | 60/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 62.02% | -1.04% | 0.17% | 55/142 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 61.92% | 1.78% | -3.44% | 59/142 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 64.12% | 7.41% | 5.33% | 49/142 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 60.87% | 0.61% | -2.87% | 66/142 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 62.67% | 2.91% | 3.02% | 47/142 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 60.83% | 1.63% | 1.91% | 56/142 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 59.69% | 2% | -1.34% | 40/142 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 60.51% | 1.57% | -0.65% | 59/142 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 60.9% | 4.22% | 1.74% | 31/142 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 59.86% | 2% | 0.48% | 38/142 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 59.57% | -2.31% | 1.95% | 55/142 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 58.43% | 2% | -4.18% | 24/142 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2017-12-31 | 60.98% | 2% | 2% | 49/142 | 56.1% | 正海生物 | 92.83% | 行业排名> |